Total Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer.

Clinical trial NCT06940388 · RECRUITING

Trial details

NCT number: NCT06940388
Sponsor: brenner baruch
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Rectal Cancer (LARC)

Start date: 2025-07-23
Primary completion: 2029-08-01
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.